ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0113

ZEB2 and MLCK1 may impair gut barrier integrity in MIF-Deficient SKG Mice

Shaghayegh Foroozan Boroojeni1, Mansi Aparnathi2, Akihiro Nakamura3, Zoya Qaiyum2 and Nigil Haroon4, 1University Health Network/University of Toronto, Toronto, ON, Canada, 2Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 3Queen's University, Kingston, ON, Canada, 4Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2025

Keywords: Inflammation, Mouse Models, Other, spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0098–0114) Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Axial Spondyloarthritis (AxSpA) is a chronic inflammatory condition that primarily affects the musculoskeletal system and has multifactorial origins. The majority of AxSpA patients experience gut inflammation, with 60% having microscopic changes and 10% having overt Inflammatory Bowel Disease (IBD). Over the years, researchers have linked many pathways and cell populations to the pathogenesis of gut inflammation in AxSpA. One notable player is the macrophage migration inhibitory factor (MIF), which assumes a crucial role in AxSpA development. In a SpA mouse model (SKG mice), MIF overexpression mirrors key clinical features of AxSpA, while inhibiting or depleting MIF attenuates these symptoms. However, the exact role of MIF in SpA-related gut inflammation is unknown. In this study, we aimed to investigate the effects of MIF on intestinal barrier integrity in SKG mice.

Methods: Eight-week-old SKG mice were used for this four-arm study: SKG control mice (WT), SKG mice treated with curdlan (WT_Curdlan), SKG-MIF Knock Out (KO) mice (MKO), and SKG-MIFKO mice treated with curdlan (MKO_Curdlan). After eight weeks of curdlan/vehicle treatment, 16-week-old mice were euthanized. Formalin-fixed paraffin-embedded (FFPE) blocks of the ileum from these mice (n=2/arm) were used for single-cell RNA sequencing (scRNA-seq) Flex Gene Expression assay to investigate the effects of MIF on the expression of genes related to gut homeostasis. These results were validated by Immunohistochemistry (IHC) or qPCR in WT (n=7) and MKO (n=9) mice. Intestinal permeability was assessed in vivo using the FITC-dextran assay. Mice were administered FITC-dextran orally, and serum fluorescence was measured after 4 hours.

Results: scRNA-seq analysis revealed differential expressions of genes potentially related to gut homeostasis: Zeb2, Mylk, Muc2, Cdh1, Ocln and Cldn7, across the four arms. As compared to WT mice (± curdlan), downregulation of mucin Muc2, adherens junction protein Cdh1 and tight junction proteins Ocln and Cldn7 was observed in MKO mice (± curdlan), which was further confirmed by qPCR and IHC, respectively. These proteins are critical in maintaining gut barrier integrity. Additionally, overexpression of Zeb2 (a transcriptional repressor of Cdh1) and Mylk (responsible for endocytosis of occludin from tight junctions) was observed in MKO mice (± curdlan), further validated by IHC. These findings suggest a potential defect in intestinal epithelial regulation in the absence of MIF. Functional assessment of the intestinal barrier using the FITC-dextran assay demonstrated significantly increased intestinal permeability in MKO mice compared to WT controls (p < 0.05), consistent with the molecular findings.

Conclusion: MIF maintains gut barrier integrity by regulating the expression of ZEB2 and MLCK1. In the absence of MIF, upregulation of ZEB2 and MLCK1 disrupts the expression of Muc2, and function of epithelial tight junction (Cldn7 and Ocln) and adherens junction (Cdh1) markers, contributing to impaired barrier function and increased intestinal permeability in MKO SKG mice. These results highlight the critical role of MIF in maintaining intestinal homeostasis.


Disclosures: S. Foroozan Boroojeni: None; M. Aparnathi: None; A. Nakamura: AbbVie/Abbott, 6, Novartis, 6; Z. Qaiyum: None; N. Haroon: AbbVie, 2, Eli Lilly, 2, Janssen, 2, UCB, 2.

To cite this abstract in AMA style:

Foroozan Boroojeni S, Aparnathi M, Nakamura A, Qaiyum Z, Haroon N. ZEB2 and MLCK1 may impair gut barrier integrity in MIF-Deficient SKG Mice [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/zeb2-and-mlck1-may-impair-gut-barrier-integrity-in-mif-deficient-skg-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/zeb2-and-mlck1-may-impair-gut-barrier-integrity-in-mif-deficient-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology